The State of Texas Top Legal Officer Takes Legal Action Against Acetaminophen Manufacturers Over Autism Claims

Judicial Action
The Texas Attorney General, who supports former President Trump who is running for the United States Senate, claimed pharmaceutical manufacturers of hiding potential dangers of Tylenol

The top legal official in Texas Ken Paxton is suing the manufacturers of Tylenol, claiming the companies hid potential risks that the drug created to children's cognitive development.

The lawsuit arrives thirty days after Donald Trump promoted an unsubstantiated connection between using Tylenol - referred to as acetaminophen - throughout gestation and autism in young ones.

The attorney general is taking legal action against Johnson & Johnson, which once produced the medication, the sole analgesic approved for women during pregnancy, and Kenvue, which presently makes it.

In a statement, he claimed they "deceived the public by gaining financially from suffering and pushing pills without regard for the risks."

The company asserts there is insufficient reliable data tying Tylenol to autism spectrum disorder.

"These corporations misled for generations, intentionally threatening countless individuals to increase profits," the attorney general, a Republican, stated.

The company said in a statement that it was "seriously troubled by the perpetuation of misinformation on the reliability of acetaminophen and the potential impact that could have on the health of American women and children."

On its online platform, the company also stated it had "continuously evaluated the pertinent research and there is insufficient valid information that indicates a verified association between using paracetamol and autism spectrum disorder."

Associations speaking for physicians and healthcare providers agree.

ACOG has declared paracetamol - the primary component in Tylenol - is a restricted selection for women during pregnancy to treat discomfort and elevated temperature, which can present significant medical dangers if left untreated.

"In over twenty years of research on the utilization of acetaminophen in gestation, zero credible investigations has definitively established that the use of acetaminophen in any trimester of gestation leads to neurological conditions in children," the association stated.

The court filing cites current declarations from the Trump administration in asserting the medication is allegedly unsafe.

In recent weeks, Trump generated worry from medical authorities when he told expectant mothers to "fight like hell" not to consume acetaminophen when sick.

The US Food and Drug Administration then released a statement that physicians should consider limiting the consumption of Tylenol, while also mentioning that "a proven link" between the medication and autism in young ones has not been established.

The Health Department head Robert F Kennedy Jr, who manages the Food and Drug Administration, had pledged in April to undertake "extensive scientific investigation" that would identify the origin of autism in a matter of months.

But specialists cautioned that discovering a single cause of autism spectrum disorder - considered by experts to be the outcome of a intricate combination of genetic and environmental factors - would not be simple.

Autism spectrum disorder is a type of permanent neurological difference and condition that impacts how people experience and engage with the world, and is identified using doctors' observations.

In his court filing, Paxton - who supports Trump who is running for the Senate - alleges the manufacturer and J&J "intentionally overlooked and attempted to silence the research" around paracetamol and autism.

The lawsuit seeks to make the firms "destroy any marketing or advertising" that states acetaminophen is reliable for women during pregnancy.

The court case parallels the concerns of a collection of parents of children with autism and ADHD who sued the manufacturers of Tylenol in 2022.

Judicial authorities threw out the legal action, saying investigations from the plaintiffs' authorities was not conclusive.

Travis Hurley
Travis Hurley

A seasoned tech journalist and digital strategist with a passion for uncovering emerging trends and simplifying complex topics for readers.